From Dr. Bredesen
Chief Science Officer
October 18, 2021•From Dr. Bredesen, News
In his blog "The Next Opioid Epidemic," Dr. Dale Bredesen discusses that Alzheimer's drug development is driven by coercion, billions of dollars of profit, an established infrastructure network influenced by bias — all mirroring the opioid crisis. Read More »
September 21, 2021•From Dr. Bredesen, News
September is Alzheimer's month and the best thing we can do to mark the occasion is to reduce the frequency of this horrible, all-too-common disease. Read More »
August 20, 2021•From Dr. Bredesen, News
The First Survivors of Alzheimer’s
Dr. Bredesen thanks the efforts of all of the Alzheimer's survivors celebrating their success and courage in reversing Alzheimer's disease in his book "The First Survivors of Alzheimer's." Read More »
July 21, 2021•From Dr. Bredesen, News
Momentum is gathering for a new Alzheimer-destroying tsunami. To successfully treat chronic illnesses such as Alzheimer's we must go beyond the prescription pad to include algorithms, volumetric imaging, larger data sets, personalized protocols, and more. Read More »
June 18, 2021•From Dr. Bredesen, News
Far Reaching Implications of the Aducanumab Debacle
Dr. Bredesen discusses the far reaching implications of the FDA's controversial approval of the drug Aduhelm, rejected by its own independent advisory panel. Read More »
June 7, 2021•From Dr. Bredesen, News
Finally — Clinical Trial Demonstrates Reversal of Cognitive Decline
Dr. Bredesen writes about his successful clinical trial using precision medicine that addresses the multiple causes of Alzheimer's. Read More »
April 16, 2021•From Dr. Bredesen, News
Twists & Turns in a March for the Cure
The key to sustainable cognitive improvement is a multifactorial approach for the treatment of Alzheimer’s, identifying and addressing the root cause contributors to the decline. Read More »
March 17, 2021•From Dr. Bredesen
Spring Ahead for Better Health
Dr. Bredesen explains that living counter to our internal clocks (circadian rhythms) increases the risk for obesity, diabetes, hypertension, and heart disease, which are known risk factors for cognitive decline. Read More »